Here, we developed a CRISPR-Trap strategy that efficiently inserts a donor gene trap (SA-CMV-Venus) cassette into the BCR/ABL-specific fusion point in the CML K562 human cell line. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.